A Preview Of Champions Oncology's Earnings
Portfolio Pulse from Benzinga Insights
Champions Oncology (NASDAQ:CSBR) is set to release its quarterly earnings report on September 11, 2024. Analysts expect an EPS of -$0.03. The company's past performance shows mixed results, with a notable EPS beat last quarter leading to a 2.54% stock price increase. Shares are currently trading at $4.23, down 23.09% over the past year.
September 10, 2024 | 2:51 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Champions Oncology is expected to report an EPS of -$0.03. Investors are keen on the earnings report, especially after last quarter's EPS beat led to a stock price increase. Current stock performance is down 23.09% over the year.
The upcoming earnings report is crucial for CSBR as it could influence short-term stock movements. Last quarter's positive EPS surprise led to a stock price increase, indicating potential volatility around earnings announcements. However, the stock's overall negative performance over the past year suggests cautious investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100